A Seoul Gathering Poised to Redefine Korea’s Biotech Future
The Seoul roundtable aims to boost Korea's biopharmaceutical industry, aligning with evolving U.S. policies. Kang Kum-sil of One Law Partners is expected to provide pivotal legal insights, steering discussions toward…